Consumer Defensive
Live Price
Offline$40.35
+4.13% today
1Y Change
+7.62%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Universal Technical Institute, Inc. (UTI) is a Consumer Defensive stock with a market cap of $2.03B and listed on NYSE. The stock last traded around $40.35 and up 7.6% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of +14.0%, EPS growth of +50.6%, a dividend yield of 0.0%. What stands out right now is revenue +14.0%, EPS +50.6%, free cash flow -10.1% with operating margin 8.4% and ROIC 9.3%. Valuation already assumes a fairly strong business story at P/E 37.5 and price/sales 2.4. Stock Foundry combines UTI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UTI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UTI Max Drawdown
-37.37%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UTI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$335.1M
-20.0% YoY
FY Net Income
$14.6M
-43.6% YoY
Free Cash Flow
-$6.4M
+80.9% YoY
Revenue Growth
+14.0%
EPS Growth
+50.6%
Gross Margin
49.5%
Net Margin
6.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 836M | 733M | 607M | 419M | 335M |
| Gross Profit | 415M | 348M | 276M | 212M | 168M |
| Operating Income | 83M | 59M | 21M | 22M | 15M |
| EBITDA | 147M | 117M | 74M | 55M | 45M |
| Net Income | 63M | 42M | 12M | 26M | 15M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 127M | 162M | 152M | 66M | 134M |
| Total Assets | 826M | 745M | 741M | 553M | 513M |
| Total Liabilities | 498M | 484M | 515M | 338M | 324M |
| Shareholder Equity | 328M | 260M | 226M | 215M | 189M |
| Total Debt | 279M | 295M | 350M | 210M | 198M |
| Net Debt | 152M | 133M | 198M | 143M | 64M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
55M
+19.9% YoY
Capital Expenditures
62M
+22.5% YoY
Free Cash Flow
6M
+80.9% YoY
Key ratios
Gross Margin
49.5%
Operating Margin
8.4%
Net Margin
6.3%
ROE
17.0%
Debt / Equity
1.37x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.